RETTEN TO GO - RS

0
RETTEN TO GO - RS
RETTEN TO GO - RS is an Android app from Georg Thieme Verlag KG New in the Medical category, currently rated — across few ratings. Initial signal reads as mostly critical sentiment so far: users flag rough edges and unmet expectations.
Quality Score is 0: Niche (micro-niche or pre-traction stage). For a Medical app, that means micro-niche or pre-traction stage. The full BU Investment Matrix below scores 8 dimensions including monetisation, growth, and operational risk.
Track changes month-over-month in the Performance section below: live snapshot history and revenue forecast included.
- Title & subtitle keyword fit
- Description hook & conversion structure
- Screenshots, ratings, reviews strategy
📊 Performance Tracking LIVE
Synthetic estimate. Inputs: category complexity, file size, screen count, monetization layer, platform reach, age × team-size proxy. Calibrated against 2024-2026 indie-agency rate surveys. Full math + source list on /methodology.
| 🧱MVP baseline (design + 1-store ship) | +$28K |
| 📱5 unique screens × $4.5K | +$22K |
| ⚙Medical complexity ×1.55 | +$27K |
| 🌐Cross-platform reach (iOS + Android) | +$43K |
Heuristic guess from app bundle size, category, store description signals, and release-date stack era. Bumetric does not disassemble binaries — for binary-level certainty you would need an SDK intelligence tool or the manifest itself. Reasoning chain on the right. Full ruleset on /methodology.
| 🏷Category context | Medical |
| 📦Compact Android bundle | → Native Kotlin |
How we forecast this revenue
LOW CONFIDENCEBU Investment Matrix
Early-stage solo · 44/100INDIE TIERexpected for tier- 💰 Revenue: Marginal — $200 - $1250/mo · INDIE tier · medium confidence, trajectory unclear.
- ⭐ Quality: 4.2★ across 117 reviews — below category median.
- 📍 Market: Not yet charting in any of the 9 monitored markets.
- 📈 Growth: Insufficient signal to assess trajectory.
- ⚠️ Risk: Low — no material risk signals detected.
💰 Forecast Revenue / mo
MODEL📈 Reviews Growth
LIVE⭐ Rating Trend
LIVE📝 About this app
• Searched. Found.
Find fast answers to your questions. In the search with more than 2,800 technical terms and buzzwords. So you have your mobile lexicon always.
• Learning and celebrating success.
Set flashcards that you have noticed you, to "I can". Remember you your Wackelkandidaten and repeat it at a later date. Celebrate soon your first success.… View full description on the official store →
Track this app’s revenue
FREEProfile & Insights
Identification
- App name
- RETTEN TO GO - RS
- Developer
- Georg Thieme Verlag KG New
- Bundle ID
- de.thieme.rettentogors
- App Store URL
- Open in App Store
- Category
- Medical
- Content rating
- Not found
- Languages
- Not found
Company
- Website
- kundenservice.thieme.de
- Tagline
- Not found
- Description
- Not found
- Founded
- Not found
- HQ / Address
- Not found
- Employees
- Not found
- Logo
- Not found
Revenue
- Verified revenue / mo
- Not found
- AI revenue estimate / mo
- Not found
- AI annual estimate
- Not found
- ML model estimate / mo
- $261/mo
- Top-grossing rank
- Not found
- All-time revenue
- Not found
- Pricing
- Not found
Founder
Funding
Press & Links
Contacts & Socials
📝 Description
95
More by Georg Thieme Verlag KG New
View all →Why low confidence: only 0 ratings · no founder-verified revenue (model estimate only) · revenue figure is directional only.
RETTEN TO GO - RS is a very early-stage Android app in the medical space with weak public traction — only 0 ratings, no founder-verified MRR, and not ranked in any monitored grossing chart. The app appears to be monetised, but public signals are too sparse for a precise revenue estimate.
Bottom line: treat all revenue, audience and acquisition-value numbers on this page as directional only — not founder-verified facts.




